Biological markers in CSF and blood for axonal degeneration in multiple sclerosis (Q35994386)

11 August 2017

1 reference

title

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis (English)

1 reference

11 August 2017

0 references

Charlotte E Teunissen

series ordinal

1

1 reference

PubMed ID

15620855

11 August 2017

Christine Dijkstra

series ordinal

2

1 reference

PubMed ID

15620855

11 August 2017

Chris Polman

series ordinal

3

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

1

1 reference

11 August 2017

32-41

1 reference

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal damage in acute multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Dendritic and Synaptic Pathology in Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal changes in chronic demyelinated cervical spinal cord plaques

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Increase of sodium channels in demyelinated lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Development of biomarkers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Cerebrospinal fluid markers in MS patients and their healthy siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

A structural scaffolding of intermediate filaments in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Elevated neurofilament levels in neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Increased cerebrospinal fluid tau protein in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Proteomic analysis of multiple sclerosis cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Neurofilaments are obligate heteropolymers in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Tau, where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Dynamics of brain-derived proteins in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Serum tau protein level as a marker of axonal damage in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Diagnostic use of cerebral and extracerebral oxysterols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Genetic polymorphism in human apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E and the CNS response to injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Increased 3-nitrotyrosine in brains of Apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Meta-analysis of genome searches

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E genotype does not influence the progression of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

APOE genotype is a major predictor of long-term progression of disability in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Amyloid precursor protein (APP) expression in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Imaging neuronal and axonal degeneration in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

14-3-3 proteins in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Biomarkers for Alzheimer's disease. Which way to go?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Effect of dietary vitamin E on lipofuscin accumulation with age in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900964-0

7 January 2021

10.1016/S1474-4422(04)00964-0

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15620855